Cholinergic Stimulation Prevents the Development of Autoimmune Diabetes: Evidence for the Modulation of Th17 Effector Cells via an IFNγ-Dependent Mechanism

Type I diabetes (T1D) results from T cell-mediated damage of pancreatic β-cells and loss of insulin production. The cholinergic anti-inflammatory pathway represents a physiological link connecting the central nervous and immune systems via vagus nerve, and functions to control the release of proinfl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: George, Junu A., Bashir, Ghada, Qureshi, Mohammed M., Mohamed, Yassir A., Azzi, Jamil, al-Ramadi, Basel K., Fernández-Cabezudo, Maria J.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2016
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5061850/
https://ncbi.nlm.nih.gov/pubmed/27790217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00419
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars